COMPARISON OF PRE AND POST-TURP EVALUATION IN BPH PATIENTS USING IPSS AND UROFLOWMETRY IN TERTIARY HOSPITAL

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

PDF
Published 2024-09-06
Fikri Alam Riza Putra Besut Daryanto Andri Kustono

Abstract

Objective: To present the data about LUTS using International Prostatic Symptoms Score (IPSS) and uroflowmetry on BPH patients following TURP. Material & Methods: This retrospective study reviewed patients diagnosed as BPH with LUTS undergone TURP from Dr. Saiful Anwar General Hospital medical records from January 2021 to January 2023. The basic clinical characteristics, IPSS, and uroflowmetry results were collected. Furthermore, the comparison of IPSS score and uroflowmetry prior and 7 days after surgery were analyzed. Results: From a total of 286 patients, 94 patients met the inclusion criteria. Improvement of LUTS and quality of life (QoL) obtained from IPSS were observed before and after TURP (19.13 vs 2.78, p<0.001; 4.38 vs 0.33, p<0.001). Similar improvement was also showed for maximum flow rate (QMax) and post-void residual (PVR) volume obtained from uroflowmetry result (7.90 vs 17.85, p<0.001; 66.25 vs 27.05, p<0.001) with 90.43% patients had Qmax >15 ml/sec after the procedure. Conclusion: This study showed the evidence of early improvement of IPSS and uroflowmetry results in BPH patients after TURP. The indicators were sufficient to evaluate the satisfaction result of patient complaining LUTS. Keywords: BPH, IPSS, uroflowmetry, TURP.


##plugins.themes.bootstrap3.article.details##

Keywords

BPH, IPSS, uroflowmetry, TURP

References

Prasetyo ZA, Budaya TN, Daryanto B. Characteristics of Benign Prostatic Hyperplasia (BPH) Patients Undergoing Transurethral Resection of the Prostate (TURP). J Kedokt Brawijaya. 2021; 31(4): 220-223.

Budaya TN, Daryanto B. A to Z BPH (Benign Prostatic Hyperplasia). 1st ed. Malang: UB Press; 2019.

Güler C, Tüzel E, Doğantekin E, Kızıltepe G. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?. Urologia internationalis. 2008. 19; 80(2): 181-5.

Djavan B, Margreiter M, Dianat SS. An algorithm for medical management in male lower urinary tract symptoms. Current opinion in urology. 2011. 1; 21(1): 5-12.

Von Garrelts B. Analysis of micturition; a new method of recording the voiding of the bladder. Acta chirurgica scandinavica. 1957. 28; 112(3-4): 326-40.

Daryanto B, Budaya TN, Meiyanto JD. Short-Term Complications of Transurethral Resection of The Prostate Performed by Urology Resident in Educational Hospital: Characteristics And Determinant Factors. Indonesian Journal of Urology. 2024; 4.

Narendra J, Sathishkumar N, Ravikumar G. Comparative Evaluation of Uroflowmetric Parameters in Patients with Benign Prostatic Hyperplasia Undergoing Transurethral Resection of the Prostate. Journal of Clinical & Diagnostic Research. 2019. 1; 13(12).

Amu OC, Udeh EI, Ugochukwu AI, Dakum NK, Ramyil VM. The value of international prostate symptom scoring system in the management of BPH in Jos, Nigeria. Niger J Clin Pract. 2013; 16(3): 273-8.

Ugraiah AB, Shyam S. Correlation of international prostate symptom score and uroflowmetry in evaluation of benign prostatic hyperplasia. International Surgery Journal. 2020. 23; 7(10): 3381-8.

Patandung R, Warli SM. Outcome benefits to transurethral resection of the prostate in patients with benign prostatic hyperplasia at Medan regional hospital. JKKI: Jurnal Kedokteran dan Kesehatan Indonesia. 2021; 31: 137-43.

Vesely S, Knutson T, Damber JE, Dicuio M, Dahlstrand C. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scandinavian journal of urology and nephrology. 2003; 37(4): 322-8.

Bosch JLHR, Hop WCJ, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. British Journal of Urology. 1995; 75: 622-30.

Barry MJ, Girman CJ. Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study group. J Urol. 1995; 153(1): 99-103

Din KEE, Kiemeney LAAM, Wildt MJAM, Debruyne FMJ, Rosette JJMC. Correlation between uroflowmetry, prostate volume, postvoid residual, and lower urinary tract symptoms measured by the International Prostate Symptom Score. Urol. 1996; 48: 393-7.

De la Rosette JJ, Alivizatos G, Madersbacher S, Perachino M, Thomas D, Desgrandchamps F, de Wildt M. EAU Guidelines on benign prostatic hyperplasia (BPH). European urology. 2001. 29; 40(3): 256-63.

Section
Articles
Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University